StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
5
Publishing Date
2021 - 09 - 28
1
2021 - 09 - 24
1
2021 - 09 - 09
1
2021 - 05 - 04
1
2021 - 04 - 07
1
Sector
Health technology
5
Tags
Acquisition
9
Active
10
Antiviral
10
Application
24
Approval
31
Authorization
14
Breast
12
Cancer
66
Candidate
16
Children
18
Clinical-trials-phase-ii
9
Clinical-trials-phase-iii
15
Collaboration
21
Comirnaty®
10
Conference
18
Covid
58
Covid-19
41
Disease
28
Drug
54
Earnings
20
Ema
10
Emergency use authorization
10
Europe
13
Events
12
Expected
10
Fda
74
Fda-approvals
14
Financial
19
Global
56
Growth
29
Hiv
15
Hormone
10
License
19
Market
100
Merge
15
N/a
432
Order
15
People
24
Pharm-country
33
Pharmaceutical
17
Phase 2
12
Phase 3
21
Positive
45
Potential
11
Product-news
10
Regulatory
12
Report
49
Research
51
Respiratory
10
Results
62
Risk
16
Study
20
Therapeutics
40
Therapy
29
Topline
14
Treatment
73
Trial
47
Ulcerative colitis
12
Update
14
Vaccine
106
Entities
Glaxosmithkline plc
2
Myovant sciences ltd.
1
Pfizer, inc.
5
Symbols
ABBV
4
ACAD
3
ACER
4
AGIO
3
ALDX
2
ALNY
4
AMGN
5
AMYT
2
AQST
3
ARDX
2
ARQT
2
ATXI
2
AVDL
3
AXSM
3
AZN
2
AZNCF
2
BGNE
3
BIIB
3
BYSI
3
CCCC
2
CGEM
2
CYBN
2
ETON
2
EXEL
3
FBIO
2
FENC
6
FNCTF
2
GILD
3
GSK
2
INCY
9
ITRM
2
JNJ
2
KRON
2
LCI
2
LJPC
2
LLY
11
MNKD
7
MRK
2
MRNS
3
MRTX
2
MYOV
5
NUVB
3
NVO
2
OBSV
2
OCGN
6
OCUL
2
ONTX
3
OYST
2
PCRX
2
PFE
5
PTE
4
RMTI
3
RYTM
3
SNY
7
SNYNF
4
TAK
3
UTHR
7
VRCA
4
VRDN
4
VRPX
3
Exchanges
Nasdaq
1
Nyse
5
Crawled Date
2021 - 09 - 28
1
2021 - 09 - 24
1
2021 - 09 - 09
1
2021 - 05 - 04
1
2021 - 04 - 07
1
Crawled Time
06:00
1
11:00
1
12:00
2
13:00
1
Source
www.biospace.com
3
www.globenewswire.com
1
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
New drug
symbols :
PFE
save search
FDA grants Priority Review to ViiV Healthcare’s New Drug Application for cabotegravir long-acting for prevention of HIV
Published:
2021-09-28
(Crawled : 12:00)
- biospace.com/
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-40.33%
|
O:
-1.15%
H:
0.49%
C:
-0.07%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
3.25%
|
O:
-0.73%
H:
0.13%
C:
-0.44%
new drug
fda
drug
hiv
application
granted
grant
Everest Medicines Announces Approval of Investigational New Drug Application by China NMPA for SPR206
Published:
2021-09-24
(Crawled : 06:00)
- prnewswire.com
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-41.16%
|
O:
-0.27%
H:
0.0%
C:
0.0%
new drug
china
drug
approval
application
Myovant Sciences and Pfizer Announce FDA Acceptance of Supplemental New Drug Application for MYFEMBREE® for the Management of Moderate to Severe Pain Associated With Endometriosis
Published:
2021-09-09
(Crawled : 11:00)
- globenewswire.com
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-44.1%
|
O:
-0.09%
H:
0.53%
C:
-0.95%
MYOV
|
$26.98
-0.04%
0.0%
0
|
Health Technology
|
4.53%
|
O:
-0.54%
H:
1.56%
C:
-2.22%
new drug
fda
fda acceptance
drug
ViiV Healthcare initiates rolling submission of new drug application with US FDA for long-acting cabotegravir for prevention of HIV
Published:
2021-05-04
(Crawled : 13:00)
- biospace.com/
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-34.72%
|
O:
0.43%
H:
0.43%
C:
-0.13%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
5.52%
|
O:
-0.19%
H:
0.29%
C:
-0.27%
new drug
fda
drug
hiv
submission
application
Pfizer Announces Extension of Review of New Drug Application of Abrocitinib for the Treatment of Moderate to Severe Atopic Dermatitis
Published:
2021-04-07
(Crawled : 12:00)
- biospace.com/
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-27.88%
|
O:
-0.06%
H:
0.58%
C:
-0.33%
new drug
treatment
dermatitis
drug
atopic dermatitis
application
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.